Namouni Fouad
PRESIDENT, R & D at BPMC
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Mar 5, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BPMCBlueprint Medicines CorpPRESIDENT, R & D
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BPMCPlan not statedOct 5, 2021 2021
Sold 3,241 shares at $98.18 ($318k)
Namouni Fouad, President, R & D
Sold 7.1% of holdings ($4.5M position)42,321 shares leftFirst sale on recordFiling
- 2 Form 4 sale BPMCPlan not statedMar 7, 2022 +153 days
Sold 1,047 shares at $56.19 ($59k)
Namouni Fouad, PRESIDENT, R & D
Sold 1.8% of holdings ($3.2M position)56,274 shares leftFiling
- 3 Form 4 sale BPMCPlan not statedOct 4, 2022 +211 days
Sold 3,477 shares at $67.30 ($234k)
Namouni Fouad, PRESIDENT, R & D
Sold 6.2% of holdings ($3.8M position)52,797 shares leftFiling
- 4 Form 4 sale BPMCPlan not statedMar 6, 2023 +153 days
Sold 1,948 shares at $45.68 ($89k)
Namouni Fouad, PRESIDENT, R & D
Sold 2.9% of holdings ($3.1M position)65,849 shares left0.6x usual sizeFiling
- 5 Form 4 sale BPMCNo planOct 4, 2023 +212 days
Sold 3,769 shares at $48.06 ($181k)
Namouni Fouad, PRESIDENT, R & D
No 10b5-1 planSold 5.7% of holdings ($3.2M position)62,080 shares left1.5x usual sizeFiling
- 6 Form 4 sale BPMCNo planMar 7, 2024 +155 days
Sold 4,377 shares at $90.69 ($397k)
Namouni Fouad, PRESIDENT, R & D
No 10b5-1 planSold 5.7% of holdings ($7M position)72,703 shares left1.3x usual sizeFiling
- 7 Form 4 sale BPMCNo planOct 3, 2024 +210 days
Sold 3,633 shares at $89.32 ($324k)
Namouni Fouad, PRESIDENT, R & D
No 10b5-1 planSold 5% of holdings ($6.5M position)69,070 shares left1x usual sizeFiling
- 8 Form 4 sale BPMCNo planMar 5, 2025 +153 days
Sold 6,489 shares at $88.80 ($576k)
Namouni Fouad, PRESIDENT, R & D
No 10b5-1 planSold 7.9% of holdings ($7.3M position)75,781 shares left1.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Mar 7, 2025 | BPMC | PRESIDENT, R & D | Form 4 sale | 6,489 | $576k | 7.9% | No plan | SEC |
| Oct 3, 2024 | Oct 4, 2024 | BPMC | PRESIDENT, R & D | Form 4 sale | 3,633 | $324k | 5.0% | No plan | SEC |
| Mar 7, 2024 | Mar 11, 2024 | BPMC | PRESIDENT, R & D | Form 4 sale | 4,377 | $397k | 5.7% | No plan | SEC |
| Oct 4, 2023 | Oct 5, 2023 | BPMC | PRESIDENT, R & D | Form 4 sale | 3,769 | $181k | 5.7% | No plan | SEC |
| Mar 6, 2023 | Mar 8, 2023 | BPMC | PRESIDENT, R & D | Form 4 sale | 1,948 | $89k | 2.9% | Plan not stated | SEC |
| Oct 4, 2022 | Oct 5, 2022 | BPMC | PRESIDENT, R & D | Form 4 sale | 3,477 | $234k | 6.2% | Plan not stated | SEC |
| Mar 7, 2022 | Mar 8, 2022 | BPMC | PRESIDENT, R & D | Form 4 sale | 1,047 | $59k | 1.8% | Plan not stated | SEC |
| Oct 5, 2021 | Oct 7, 2021 | BPMC | President, R & D | Form 4 sale | 3,241 | $318k | 7.1% | Plan not stated | SEC |